BAT2206

DRUG2 trials

Sponsors

Bio-Thera Solutions

Conditions

Plaque PsoriasisPsoriasis

Phase 1

Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

CompletedNCT04371185

Bio-Thera SolutionsPsoriasis

Start: 2020-08-08End: 2021-04-19Updated: 2021-09-13

Phase 3

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

CompletedNCT04728360

Bio-Thera SolutionsPlaque Psoriasis

Start: 2021-07-06End: 2023-07-07Updated: 2023-07-21

Related Papers

Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial.

2022-11-228 citations